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Biologists have long known that posttranslational
modifications (PTMs), such as phosphorylation, play im-
portant regulatory roles in eukaryotic signaling. However,
the pervasiveness of such regulation was not fully appreci-
ated until the beginning of this millennium, when
sequencing of the human genome revealed far fewer
protein-coding genes than anticipated. This finding led to
the appreciation that PTMs may provide an important
layer in diversifying the regulatory landscape of proteomes.
A challenge was then to map the landscape of PTM-based
regulation. Concurrent with the emergence of the geno-
mic era, mass spectrometry (MS) emerged as a powerful
tool for identifying proteins and for focused analysis of
PTMs. Initially, however, the sensitivity and the resolu-
tion of MS instruments were not sufficiently high for
large-scale PTM mapping. The situation changed mark-
edly with the commercial introduction of Orbitrap-based
mass spectrometers in 2005 and sample-preparation and
bioinformatics advances. By combining these tools with
efficient phosphorylated peptide enrichment strategies and
SILAC (stable isotope labeling by amino acids in cell
culture)-based quantification, our group provided the first
time-resolved map of phosphorylation in human cells (1).
Successful decoding of the human phosphopro-
teome encouraged us to explore lesser known PTMs, in
particular, lysine acetylation. Although acetylation was
discovered in the early 1960s, just a few years after the
discovery of phosphorylation, the fate of these PTMs
diverged greatly in subsequent years. Phosphorylation
was identified on hundreds of proteins and established
as a major regulatory PTM in cell signaling, whereas for
decades, acetylation remained confined to just a few
proteins, mostly histones and tubulin. The picture
started to change in the mid- to late 1990s following a
wave of discoveries, including the identification of the
first acetyltransferases and deacetylases and the bromo-
domain as an acetyllysine reader. Furthermore, acetyla-
tion was described for transcription factors, most
prominently the tumor suppressor p53. This led to
speculation that the regulatory scope of acetylation
could rival that of phosphorylation (2). However, with-
out a proper toolbox for identification and quantifica-
tion, it was difficult to confirm this prediction and to
identify which proteins and which of their lysine
residues were modified by acetylation. Armed with the
latest MS technology, and with antiacetyllysine antibod-
ies sufficiently specific for enrichment, we started to ex-
plore the “acetylome” in depth. We were elated to find
that even with a few trial MS runs, we were able to iden-
tify more acetylation sites than reported in all previous
studies in the literature combined. Nevertheless, our
depth was still limited to about 1000 acetylation sites.
To increase the depth of acetylated peptide sequencing,
we used the so-called OFFGEL-based peptide fraction-
ation approach to separate peptides following the
acetylated peptide–enrichment step. This enabled us to
isolate and sequence low abundant peptides, greatly
enhancing the depth of measured acetylome. Finally, to
enable site-specific relative quantification of acetylation,
we combined these approaches with the SILAC
method. As reported in our 2009 article discussed here,
This powerful combination identified approximately
3600 acetylation sites on 1750 proteins, dramatically
expanding the known universe of lysine acetylation.
For the first time, these data allowed systematic assess-
ment of the global properties of this PTM. Contrary
to common beliefs, it turned out that acetylation
was not just confined to the nucleus but rather oc-
curred across diverse subcellular compartments, even
in mitochondria, where protein phosphorylation is
underrepresented. Notably, we detected acetylation on
multiple components of large protein complexes, sug-
gesting their coregulation. Furthermore, our quantita-
tive analyses of lysine deacetylase inhibitor–regulated
a Proteomics Program, the Novo Nordisk Foundation Center for Protein Research, Faculty
of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
b Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Martinsried,
Germany.
*Address correspondence to: C.C. at Proteomics Program, the Novo Nordisk Foundation
Center for Protein Research, Faculty of Health and Medical Sciences, University of
Copenhagen, Blegdamsvej 3B, DK2200, Copenhagen, Denmark; E-mail chuna.
choudhary@cpr.ku.dk. M.M. at Proteomics and Signal Transduction, Max Planck
Institute for Biochemistry, 82152 Martinsried, Germany; E-mail mmann@biochem.
mpg.de.
1This article has been cited more than 2400 times since publication.
Received March 25, 2020; accepted March 27, 2020.
DOI: 10.1093/clinchem/hvaa087
VC American Association for Clinical Chemistry 2020.
This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unre-
stricted reuse, distribution, and reproduction in any medium, provided the original
work is properly cited.
852
Clinical Chemistry 66:6 Citation Classic852–853 (2020)
D
ow
nloaded from
 https://academ
ic.oup.com
/clinchem
/article/66/6/852/5836062 by D
anish R
egions user on 14 August 2020
acetylation revealed that inhibition of classical zinc-
dependent deacetylases affected a much smaller subset
of the acetylome than previously thought. Together,
these results demonstrated that our approach enabled
unbiased, systems-wide quantification of perturbation-
induced acetylation changes.
In addition to providing a high-confidence set of
acetylation sites and revealing global properties of acety-
lation, our work raised many new questions about the
occurrence of acetylation in evolutionarily diverse organ-
isms, the mechanism causing acetylation (enzymatic vs
nonenzymatic), and the dynamics and stoichiometry of
this PTM. In the ensuing years, we combined quantita-
tive MS with chemical and genetic tools to reveal the
stoichiometry and dynamics of acetylation. Perhaps sur-
prisingly, these analyses clearly demonstrated that most
acetylation sites have very low stoichiometry (<1%) and
that a vast majority of acetylation events in bacteria, and
a large fraction of mitochondrial acetylation, occur
through nonenzymatic reactions (3–5). Although much
remains to be learned about the biological functions, ki-
netics, and enzymatic regulation of acetylation, the pio-
neering work discussed here firmly put acetylation on
the global map of reversible modifications. We antici-
pate that in the next decade, these discoveries will be
translated into further functional understanding of how
acetylation and related regulatory enzymes control di-
verse biological processes and how dysregulation affects
disease states.
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